Here are five notes:
1. Mr. Ishrak’s compensation at the end of the fiscal year totaled $40.5 million, according to a proxy.
2. Around $25.5 million of that was a tax gross-up payment coming out of the Medtronic-Covidien merger.
3. Mr. Ishrak earned $15 million this year before the tax gross-up, compared to $8.3 million he earned last year.
4. His annual incentive bonus was $5.6 million, up from $4.7 million last year.
5. The value of Mr. Ishrak’s restricted stock that vested increased from $2.1 million to $7.8 million.
More articles on devices:
SeaSpine adds leaders: 6 takeaways
Materialise, Lima Corporate sign agreement for 3D patient-specific surgical guides: 3 key notes
Amedica reveals expected Q2 2015 financial results, FDA response: 5 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
